Ventaris Surgical Inc.

Ventaris Surgical Inc. is a US-based company dedicated to developing advanced investigational medical devices aimed at addressing critical healthcare needs and improving patient outcomes across various therapeutic areas. Ventaris Surgical Inc. , founded in 2024 in San Carlos, US, focuses on the development of investigational medical devices for clinical settings.

The company has completed its first deal and raised USD 30 mn in Series A funding led by Longitude Capital, with participation from Vensana Capital, Atypical Ventures, NeoTribe Ventures, and Boutique Venture Partners in January 2026, marking a key milestone in its operational strategy. Ventaris specializes in investigational medical devices designed to meet specific healthcare needs. The company’s core offerings are aimed at improving patient outcomes in various therapeutic areas, with devices currently under development for use in clinical settings. Target customers include healthcare providers, research institutions, and hospitals, particularly in North America and Europe, where there is a demand for advanced medical solutions.

Ventaris generates revenue primarily through research partnerships and clinical collaborations, rather than traditional retail sales. Revenue arises from agreements with healthcare institutions that utilize their investigational products during clinical trials, with terms that establish the scope of research and associated financial arrangements. Specific pricing models for these products remain undisclosed, indicating that revenue is likely derived from negotiated contracts aligned with the development and testing of their medical devices. Looking ahead, Ventaris plans to leverage the USD 30 mn raised in Series A funding to expedite the development of new investigational medical devices.

The company is targeting expansion into new markets in both North America and Europe by the end of 2026, focusing on enhancing its portfolio and reaching a broader customer base. This strategic growth will include launching new devices and strengthening partnerships with healthcare providers to improve patient care.